| Entry |
|
|---|
| Name |
Levosalbutamol (INN);
Levalbuterol |
|---|
| Formula |
C13H21NO3
|
|---|
| Exact mass |
239.1521
|
|---|
| Mol weight |
239.3107
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
|
|---|
| Remark |
| Product (DG01235): | D02281<US> D04703<US> |
|
|---|
| Efficacy |
Antiasthmatic, beta2-Adrenergic receptor agonist |
|---|
| Comment |
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
DG01235 Levalbuterol
D08124 Levosalbutamol
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRB2
D08124 Levosalbutamol (INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01455 beta-Adrenergic receptor agonist
DG01452 beta2-Adrenergic receptor agonist
DG01235 Levalbuterol
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 17
1 C8y C 23.5900 -17.9200
2 C8x C 22.3300 -18.6200
3 C1c C 24.7800 -18.6200
4 C8x C 23.5900 -16.5200
5 C8y C 21.1400 -17.9200
6 C1b C 25.9700 -17.9200
7 O1a O 24.7800 -20.0200
8 C8x C 22.3300 -15.8200
9 C8y C 21.1400 -16.5200
10 C1b C 19.9500 -18.6200
11 N1b N 27.2300 -18.6200
12 O1a O 19.9500 -15.8200
13 O1a O 18.6900 -17.9200
14 C1d C 28.4200 -17.9200
15 C1a C 29.6100 -18.6200
16 C1a C 28.4200 -16.5200
17 C1a C 29.6100 -17.2200
BOND 17
1 1 2 1
2 1 3 1
3 1 4 2
4 2 5 2
5 3 6 1
6 3 7 1 #Down
7 4 8 1
8 5 9 1
9 5 10 1
10 6 11 1
11 9 12 1
12 10 13 1
13 11 14 1
14 14 15 1
15 14 16 1
16 8 9 2
17 14 17 1
|
|---|
